High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Abroad (travel likely)RecruitingPHASE2

Conditions

Immunization; Infection · Transplantation Infection · Influenza

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Study coordinator (Natasha Halasa, MD, MPH) · natasha.halasa@vumc.org · 615-322-2250
Contact: Principal Investigator (Natasha Halasa, MD)
Contact: Principal Investigator (Anil Trindade, MD)

Study leads

Natasha Halasa, MD. MPH
Principal Investigator
Vanderbilt University Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

Immunization; Infection|Transplantation Infection|Influenza · Influenza

Abroad (travel likely)RecruitingPHASE2

Nashville, United States

Immune Responses in Health Care Personnel

Influenza

Abroad (travel likely)Recruiting

Helsinki, Finland

Bone Marrow and Peripheral Blood Immune Responses Study

Influenza

Abroad (travel likely)RecruitingPHASE4

Atlanta, United States

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

COVID19 · Influenza Vaccination · ACE Inhibitors

Abroad (travel likely)Recruiting

Terrassa, Spain